GRI Bio, Inc. Form 8-K Summary
Business Context and Reporting Period
GRI Bio, Inc. filed a Current Report on Form 8-K dated July 7, 2023, reporting results from its virtual 2023 Annual Meeting of Stockholders. The company’s common stock trades on The Nasdaq Capital Market under the symbol GRI.
Annual Meeting and Voting Results
- As of the May 18, 2023 record date, 2,918,954 shares were issued and outstanding and eligible to vote.
- A quorum of 1,172,148 shares, representing approximately 40.16% of eligible shares, was present in person or by proxy.
- Director elections: W. Marc Hertz, Ph.D., and David Szekeres were elected as Class III directors to serve until the 2026 Annual Meeting and until their successors are elected and qualified.
- Auditor ratification: Stockholders ratified the appointment of Sadler, Gibb & Associates LLC as the independent registered public accounting firm for the year ending December 31, 2023.
| Proposal | For | Against | Abstained | Broker Non-Votes |
|---|---|---|---|---|
| Election of W. Marc Hertz, Ph.D. | 1,068,309 | 1,845 | 335 | 101,659 |
| Election of David Szekeres | 1,068,073 | 1,926 | 490 | 101,659 |
| Ratification of Sadler, Gibb & Associates LLC | 1,169,668 | 1,957 | 523 | Not reported |
Financial Metrics and Material Changes
The filing does not provide revenue, profit, cash flow, margins, debt, liquidity, guidance, or other operating and financial metrics. It does not report a material change in the company’s financial condition or results of operations.
Guidance, Risks, and Unusual Items
The filing contains no new guidance, management outlook, risk disclosures, contingencies, or unusual financial items. Its primary subject is the outcome of the annual stockholder meeting.
Investor Verification Items
- Verify the director terms and board composition in subsequent company filings.
- Review the company’s 2023 financial filings for liquidity, financing needs, operating results, and going-concern considerations, which are not addressed here.
- Confirm the scope and findings of Sadler, Gibb & Associates LLC’s audit and any subsequent auditor-related disclosures.
- Review the proxy statement filed May 26, 2023 for detailed proposal descriptions and voting procedures.